Hunting Pseudogenes Where Bison Roam | GenomeWeb

By Aaron J. Sender

Willy Valdivia Granda’s latest project is bound to tick some people off. “A lot of patents might be invalidated,” he says. The algorithm he is pumping across patent databases, he says, will unmask hundreds, if not thousands, of filed gene sequences for what they really are: pseudogenes. Upon publication within several months, says the North Dakota State University grad student, “Many companies are going to get nervous.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.